# US 2020/0206245 A1 · Maintenance of aging muscle tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0206245 A1
- Document ID: US20200206245A1
- Status: Published application
- Kind: A1
- Application number: 16/693,291
- Filed: 2019-11-23
- Published: 2020-07-02
- Earliest claimed: 2011-12-13
- Assignees: Biophytis; Universite Paris 6 Pierre Et Marie Curie; Institut National de la Recherche Agronomique
- Applicants: Biophytis SA; Université Paris 6 Pierre Et Marie Curie; Institut National De La Recherche Agronomique
- Inventors: STANISLAS VEILLET; RENÉ LAFONT; ANNE-SOPHIE FOUCAULT; WALY DIOH; ANNIE QUIGNARD-BOULANGE
- Web page: https://patentgrep.com/patent/US20200206245A1

## CPC

- A61K 31/575: substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 36/21: Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A method of improving or maintaining muscle strength of aging muscle tissue.

## Claims

### Claim 1

A method of improving or maintaining muscle strength of aging muscle tissue of a sarcopenic mammal, comprising the step of administering phytoecdysones to said mammal.

### Claim 2

A method increasing protein content of muscle, comprising the step of administering phytoecdysones to a mammal suffering from sarcopenic obesity.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the phytoecdysones administered consist of 20-hydroxyecdysone.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the phytoecdysones being administered are provided in the form of a plant extract enriched with one or more phytoecdysones.

### Claim 5 (depends on 4)

The method as claimed in claim 4, wherein the extract comprises at least 1% by weight of phytoecdysones.

### Claim 6 (depends on 4)

The method according to claim 4, wherein the plant extract is derived from quinoa.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the phytoecdysones are incorporated in a composition suitable for oral administration.

### Claim 8 (depends on 1)

The method of claim 1, wherein the phytoecdysones are administered to the mammal at a dose of 5 mg of phytoecdysones per kg of body weight per day.

### Claim 9

A method improving or maintaining muscle strength of aging muscle tissue of a sarcopenic mammal, comprising a step of administering phytoecdysones to said sarcopenic mammal suffering from sarcopenia or sarcopenic obesity.

### Claim 10 (depends on 9)

The method of claim 9, further comprising the step of evaluating treatment progress by one or more of the following: measuring said mammal's lean body mass; measuring muscle triglyceride content; measuring muscle protein content; measuring gene transcript quantities in a muscle; measuring the energy balance of said mammal in terms of energy expended versus caloric intake; and measuring muscle strength using a grip test.
